The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial review an act of "radical transparency," but it is not as revolutionary as ...
Brian Beers is a digital editor, writer, Emmy-nominated producer, and content expert with 15+ years of experience writing about corporate finance & accounting, fundamental analysis, and investing.
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Stella Osoba is the Senior Editor of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果